Threshold Pharma (THLD) –
-
Form 8-K THRESHOLD PHARMACEUTICAL For: Jul 31
-
Form 425 THRESHOLD PHARMACEUTICAL Filed by: THRESHOLD PHARMACEUTICALS INC
-
Threshold Pharmaceuticals Announces Results of Annual Meeting of Stockholders
-
Threshold Pharmaceuticals Reports Second Quarter Financial Results
-
Form 10-Q THRESHOLD PHARMACEUTICAL For: Jun 30
-
Form 425 THRESHOLD PHARMACEUTICAL Filed by: THRESHOLD PHARMACEUTICALS INC
-
Form 8-K THRESHOLD PHARMACEUTICAL For: Jun 20
-
Form CT ORDER THRESHOLD PHARMACEUTICAL
-
Form EFFECT THRESHOLD PHARMACEUTICAL
-
Form 424B3 THRESHOLD PHARMACEUTICAL
-
Form S-4/A THRESHOLD PHARMACEUTICAL
-
Form 8-K THRESHOLD PHARMACEUTICAL For: Jun 16
-
Threshold Pharma (THLD) Confirms 1st Patient Dosed in Immunotherapy Clinical Trial of Evofosfamide & Ipilimumab
-
Threshold Pharmaceuticals Announces First Patient Dosed in Immunotherapy Clinical Trial of Evofosfamide and Ipilimumab
-
Form 4 THRESHOLD PHARMACEUTICAL For: May 31 Filed by: BIRD JEFFREY W
-
Form 8-K THRESHOLD PHARMACEUTICAL For: May 31
-
Threshold Pharma (THLD) Sells TH-3424 to OBI Pharma
-
OBI Pharma Announces Acquisition of TH-3424 from Threshold Pharmaceuticals
-
Form NT 10-Q THRESHOLD PHARMACEUTICAL For: Mar 31
-
Form 10-Q THRESHOLD PHARMACEUTICAL For: Mar 31
-
Form 8-K THRESHOLD PHARMACEUTICAL For: May 15
-
Threshold Pharmaceuticals Reports First Quarter Financial Results
-
Form S-4 THRESHOLD PHARMACEUTICAL
-
Form 10-K/A THRESHOLD PHARMACEUTICAL For: Dec 31
-
Form 425 THRESHOLD PHARMACEUTICAL Filed by: THRESHOLD PHARMACEUTICALS INC
-
Form 8-K THRESHOLD PHARMACEUTICAL For: Mar 30
-
Form 425 THRESHOLD PHARMACEUTICAL Filed by: THRESHOLD PHARMACEUTICALS INC
-
Form 8-K THRESHOLD PHARMACEUTICAL For: Mar 29
-
Form 10-K THRESHOLD PHARMACEUTICAL For: Dec 31
-
Form 8-K THRESHOLD PHARMACEUTICAL For: Mar 27
-
Threshold Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results
-
Form 425 THRESHOLD PHARMACEUTICAL Filed by: THRESHOLD PHARMACEUTICALS INC
-
Form 8-K THRESHOLD PHARMACEUTICAL For: Mar 16
-
Form 425 THRESHOLD PHARMACEUTICAL Filed by: THRESHOLD PHARMACEUTICALS INC
-
Threshold Pharma (THLD) to Merge with Molecular Templates
-
Threshold Pharmaceuticals and Molecular Templates Agree to Combine
-
Form SC 13G/A THRESHOLD PHARMACEUTICAL Filed by: Sio Capital Management, LLC
-
Form SC 13G/A THRESHOLD PHARMACEUTICAL Filed by: SUTTER HILL VENTURES
-
Form SC 13G THRESHOLD PHARMACEUTICAL Filed by: First Eagle Investment Management, LLC
-
Threshold Pharmaceuticals and National Cancer Institute to Collaborate on Drug Candidate TH-3424
-
Threshold Pharmaceuticals Announces Presentation and Webcast at the Stifel Healthcare Conference 2016
-
Form 8-K THRESHOLD PHARMACEUTICAL For: Nov 11
-
Threshold Pharmaceuticals Reports Third Quarter Financial Results
-
Form 10-Q THRESHOLD PHARMACEUTICAL For: Sep 30
-
Form 8-K THRESHOLD PHARMACEUTICAL For: Nov 07
-
Caris Life Sciences and Threshold Pharmaceuticals Collaborate to Utilize Caris' ADAPT Biotargeting System in the Development Program for Evofosfamide
-
Form 8-K THRESHOLD PHARMACEUTICAL For: Oct 13
-
Form 8-K THRESHOLD PHARMACEUTICAL For: Sep 29
-
Unusual 11 Mid-Day Movers 9/30: (NVFY) (AUPH) (ITUS) Higher; (VEC) (THLD) (DCTH) Lower
-
Threshold Pharma (THLD) to Discontinue Tarloxotinib Development; Will Refocus Resources
Back to THLD Stock Lookup